| 영문 | parenteral administration of drugs | 한글 | 비경구적 약품투여 |
|---|---|---|---|
| 설명 | 입을 통하지 않는 다양한 약품투여 방법을 말함. 주사기를 이용한다. 1)피하주사: subcutaneous injection-피부 밑으로 주사하는 것. 대개 팔의 중간부에 주사한다. 2)진피내주사: intradermal injection-얇게 찔러서 진피내에 주사한다. 주로 알러지 환자의 항원검사에 이용한다. 3)근육내주사: intramuscular injection-위팔이나, 혹은 엉덩이 부위에 주사한다. 이것은 주로 피부에 자극이 심한 약제나 혹은 천천히 작용하는 약제를 많이 주사할 때 사용한다. 4)혈관주사: intravenous(IV) injection-정맥을 통해 주사한다. 어느 정맥이나 가능하지만, 대개 팔뚝이나 발 등의 정맥을 이용한다. 빠른 치료효과를 보기 위해 사용한다. 이때 피부에 자극을 주는 약제이면, 새지 않도록 조심해야 한다. 5) 수막강내주사: intrathecal injection-두개나 척수강내에 주사할 때 이용한다. 6)강내주사: intracavitary injection-공간으로 된 부위에 주사한다. 예를 들어 복부공간이나 흉강내에 주사하여 사용한다. |
||
| 영문 | rectal administration of drugs | 한글 | 약물의 곧창자좌약식 투여 |
|---|---|---|---|
| 설명 | 입을 통해 먹은 약물은 흡수된 후 간을 거쳐 병변부위로 운반된다. 따라서 간에서 대사가 되어 약물로서의 효과가 없어질 가능성이 있을 뿐 아니라 간에 독성작용을 일으킬 수도 있다. 이러한 단점을 보완하기위해 간을 통하지 않고 재빨리 흡수되어 병변으로 갈 수 있는 방편으로 직장좌약을 사용한다. 직장의 정맥흐름은 간을 거치지 않고 직접 하대정맥을 통해 우심방으로 흘러들기 때문이다. |
||
| 영문 | side effects of drugs | 한글 | 약물의 부작용 |
|---|---|---|---|
| 설명 | 약을 사용할 때 기대하는 효과 외에 다른 장기에서 나타나는 원치 않는 효과를 총칭하는 말이다. 예를 들어 혈압을 낮추기 위해 항고혈압제를 사용 시, 혈압이 떨어지는 동시에 기관지의 수축이 일어나는 현상. |
||
| AVA | activity vector analysis; antiviral antibody; aortic valve area; aortic valve atresia; arteriovenous... |
|---|---|
| AVF | antiviral factor; arteriovenous fistula |
| AVP | abnormal vasopressin; actinomycin-vincristine-Platinol; ambulatory venous pressure; antiviral protei... |
| AVR | accelerated ventricular rhythm; antiviral regulator; aortic valve replacement |
| AVRR | antiviral repressor regulator |
| PAP | Pokeweed antiviral protein |
|---|---|
| ATD | Antithyroid drugs |
| DMARD | Disease Modifying Antirheumatic Drugs |
| NSAID | Non Steroid Anti-Inflammatory Drugs |
| SAARD | Slow Acting Anti-Rheumatic Drugs |
| antiviral | <pharmacology> Drugs, including interferon, which stimulate cellular defenses against viruses, reducing cell DNA synthesis and making cells more resistant to viral genes, enhancing cellular immune responses or suppressing their replication. Also refers to genetically engineered drugs that are designed to block viral replication. (14 Nov 1997) |
|---|---|
| antiviral agents | Agents used in the prophylaxis or therapy of virus diseases. They may act to prevent viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; blocking late stages of virus assembly; etc. (12 Dec 1998) |
| antiviral immunity | Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever. (05 Mar 2000) |
| antiviral protein | A human or animal factor, induced by interferon in virus-infected cells, which mediates interferon inhibition of virus replication. (05 Mar 2000) |
| veterinary drugs | Drugs used by veterinarians in the treatment of animal diseases. The veterinarian's pharmacological armamentarium is the counterpart of drugs treating human diseases, with dosage and administration adjusted to the size, weight, disease, and idiosyncrasies of the species. In the united states most drugs are subject to federal regulations with special reference to the safety of drugs and residues in edible animal products. (12 Dec 1998) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| psychotropic drugs | A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquillising agents (including the antipsychotics and anti-anxiety agents). (12 Dec 1998) |
| neuroleptic drugs | Literally nerve seising: used of chlorpromazine like drugs. Antagonise the effects of dopamine. Origin: Gr. Lepsis = a taking hold (18 Nov 1997) |
| street drugs | Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity. (12 Dec 1998) |
| designer drugs | Drugs designed and synthesised, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are mptp (a reverse ester of meperidine), mda (3,4-methylenedioxyamphetamine), and mdma (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. (12 Dec 1998) |
| drugs, chinese herbal | Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesised compounds manufactured in china. (12 Dec 1998) |
| drugs, essential | Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3) (12 Dec 1998) |
| drugs, generic | Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies. (12 Dec 1998) |
| drugs, investigational | Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries. (12 Dec 1998) |
| drugs, non-prescription | Drugs that can be sold legally without a prescription. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|